The Board of Directors of TAKE Solutions Limited, in its meeting held on May 19, 2026, has approved the appointment of Mr. Sunil Patra as the Managing Director and Chief Financial Officer of the Company, effective from May 19, 2026. The appointment of Mr. Patra as Managing Director is for a period of five years, subject to the approval of the shareholders at the next general meeting or within three months from the date of appointment, whichever is earlier. The company has also received a certificate of non-debarment from Mr. Patra in connection with his appointment.

TAKE Solutions Limited is a technology-driven healthcare solutions provider specializing in Life Sciences and Supply Chain Management. The company delivers domain-intensive services, including clinical trials, regulatory filings, pharmacovigilance, and software engineering. Recently, in 2026, the company launched a ₹5 crore Innovation Fund to invest in high-potential startups operating at the intersection of AI, deep technology, and the health and wellness sector. Additionally, the company has announced a strategic shift towards the Indian longevity and anti-aging market, planning to build a portfolio of science-backed nutraceuticals and digital wellness tools.

As of the latest shareholding data for 2026, the company’s promoter holding has transitioned to 0%, with the retail public holding the vast majority (approximately 99.71%) of the equity. Foreign Institutional Investors (FIIs) hold a negligible stake of about 0.28%. The company has faced significant financial challenges, with statutory auditors in recent quarters highlighting material uncertainty regarding its ability to continue as a going concern due to historical losses and severe business volume deterioration. During the quarter ended December 2025, the company reported no sales, and its consolidated net profit declined to ₹1.11 crore from ₹47.68 crore in the corresponding quarter of the previous year.